Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
J Med Life ; 13(4): 499-509, 2020.
Article in English | MEDLINE | ID: covidwho-1068253

ABSTRACT

Abuse of legal substances in India includes alcohol and tobacco, which are the major risk factors for various non-communicable diseases and deaths. The current pandemic has identified tobacco consumption as a risk factor for COVID-19, highlighting the need to control substance abuse. The objective of this study was to estimate the prevalence of substance abuse in India and discuss the cost-effective public health strategies (such as yoga) to alleviate COVID-related anxiety in order to prevent substance abuse and its associated co-morbidities such as type 2 diabetes mellitus. This study reports the data on tobacco and alcohol abuse from a nationwide randomized two-arm diabetes control trial (Niyantrita Madhumeha Bharata, 2017) conducted by the Indian Yoga Association (IYA) through Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bengaluru. Data of 30,354 participants who abuse tobacco and 30,159 participants who abuse alcohol were collected all over India. The prevalence is estimated at around 8.7% for alcohol abuse and 7.9% for tobacco abuse, Arunachal Pradesh state ranking the highest regarding both alcohol and tobacco abuse, while the Tripura state ranked the lowest. School and college-based mandatory yoga programs need to be implemented to prevent the increase of substance abuse in India to alleviate the psychosocial stress of adolescents and college-going students, besides the installation of the mindfulness-based diabetes yoga protocol (DYP) in the wellness centers of Ayushman Bharat.


Subject(s)
Alcohol Drinking/epidemiology , Alcoholism/epidemiology , Substance-Related Disorders/epidemiology , Tobacco Use/epidemiology , Yoga , Adult , Alcohol Drinking/prevention & control , Alcoholism/prevention & control , Anxiety , COVID-19/psychology , Cross-Sectional Studies , Diabetes Mellitus, Type 2/prevention & control , Ethanol , Female , Humans , India/epidemiology , Male , Prevalence , Randomized Controlled Trials as Topic , Risk Factors , SARS-CoV-2 , Students , Substance-Related Disorders/prevention & control , Tobacco Use/prevention & control , Universities
SELECTION OF CITATIONS
SEARCH DETAIL